Latest Breaking News On - Antiplatele - Page 1 : comparemela.com

The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or TIA, on top of dual antiplatelet therapy.

Comunidad autonoma de catalunaGiovanna liuzzoMukul sharmaMcmaster universityAcademic research consortiumCatholic university of romeEuropean society of cardiologyEuropean societyBleeding academic research consortiumCatholic universityErebrovascular accidentVa cerebrovascular accidentIschemic strokeTransient ischemic attackAnti thromboticsAntithrombotic therapy